fda semaglutide warning november 2025 🚨 Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these Medscape | The FDA has

approved on 19 February 2024)

A landmark NIH randomized controlled trial found that people consuming an ultra processed diet ate about 500 more calories per day compared to minimally processed diet

Potential anti-cancer agents that target the antioxidant enzymes In addition to traditional chemotherapeutic medications, certain agents can either target the antioxidant system or enhance the generation of ROS, potentially leading to cancer cell death

NICE has also recommended natalizumab as an option to treat adults whose disease has not responded to a full and adequate course of at least one disease-modifying therapy, if cladribine (Mavenclad